In a filing, Aspen Aerogels Inc revealed its President and CEO Young Donald R acquired Company’s shares for reported $0.11 million on May 12 ’25. In the deal valued at $5.35 per share,20,000 shares were bought. As a result of this transaction, Young Donald R now holds 550,856 shares worth roughly $3.39 million.
Then, Young Donald R sold 63,355 shares, generating $1,902,551 in total proceeds. Upon selling the shares at $30.03, the President and CEO now owns 483,640 shares.
Before that, Donald R. Young bought 134,629 shares. Aspen Aerogels Inc shares valued at $3,718,452 were divested by the President, CEO, Director at a price of $27.62 per share.
Barclays downgraded its Aspen Aerogels Inc [ASPN] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Perform”. Seaport Research Partners revised its rating on February 13, 2025. It rated ASPN as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ASPN
On Friday, Aspen Aerogels Inc [NYSE:ASPN] saw its stock fall -4.05% to $6.16. Over the last five days, the stock has gained 2.33%. Aspen Aerogels Inc shares have fallen nearly -48.15% since the year began. Nevertheless, the stocks have fallen -78.93% over the past one year. While a 52-week high of $33.15 was reached on 01/07/25, a 52-week low of $4.16 was recorded on 05/08/25.
Levels Of Support And Resistance For ASPN Stock
The 24-hour chart illustrates a support level at 6.08, which if violated will result in even more drops to 6.00. On the upside, there is a resistance level at 6.29. A further resistance level may holdings at 6.43.
How much short interest is there in Aspen Aerogels Inc?
A steep rise in short interest was recorded in Aspen Aerogels Inc stocks on 2025-05-30, growing by 0.95 million shares to a total of 9.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 8.39 million shares. There was a rise of 10.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 06, 2024 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $27 price target.
